Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Alps Alerian MLP ETF | AMLP | Nov 15, 2024 | 47.85 | +0.84 |
Alps Equal Sector Weight ETF | EQL | Nov 15, 2024 | 128.82 | -0.69 |
Alps International Sector Divid | IDOG | Nov 15, 2024 | 29.15 | +0.35 |
Alps Sector Dividend Dogs ETF | SDOG | Nov 15, 2024 | 59.01 | -0.51 |
Alset EHome International | AEI | Nov 15, 2024 | 1.04 | -3.70 |
Alt5 Sigma | ALTS | Nov 15, 2024 | 2.11 | -6.22 |
Alta Equipment A Pref | ALTG-A | Nov 15, 2024 | 25.54 | +0.04 |
Alta Equipment Group A | ALTG | Nov 15, 2024 | 6.99 | -2.92 |
Alta Global Group | MMA | Nov 15, 2024 | 1.79 | -5.79 |
Altair Engineering A | ALTR | Nov 15, 2024 | 103.75 | +0.03 |
Altamira Therapeutics | CYTO | Nov 15, 2024 | 0.46 | +5.91 |
AltEnergy Acquisition A | AEAE | Nov 15, 2024 | 11.22 | 0.00 |
AltEnergy Acquisition Unit | AEAEU | Nov 15, 2024 | 11.30 | 0.00 |
Alterity Therapeutics ADR | ATHE | Nov 15, 2024 | 1.11 | -5.56 |
Alternus Clean Energy A | ALCE | Nov 15, 2024 | 1.75 | -0.01 |
Alti Global A | ALTI | Nov 15, 2024 | 4.39 | -0.90 |
Altice USA A | ATUS | Nov 15, 2024 | 2.47 | -5.36 |
Altimmune | ALT | Nov 15, 2024 | 7.61 | -9.99 |
Altisource Portfolio Solutions | ASPS | Nov 15, 2024 | 0.87 | -0.82 |
Alto Ingredients | ALTO | Nov 15, 2024 | 1.37 | -0.72 |
Alto Neuroscience | ANRO | Nov 15, 2024 | 4.52 | -1.74 |
Altria Group | MO | Nov 15, 2024 | 55.93 | +0.97 |
Altus Power A | AMPS | Nov 15, 2024 | 3.85 | -6.10 |
Alumis | ALMS | Nov 15, 2024 | 8.85 | -5.95 |
Alvotech | ALVO | Nov 15, 2024 | 11.73 | -2.82 |
ALX Oncology | ALXO | Nov 15, 2024 | 1.29 | -3.01 |
Alzamend Neuro | ALZN | Nov 15, 2024 | 1.36 | -6.85 |
Amalgamated Financial | AMAL | Nov 15, 2024 | 35.56 | -2.47 |
Amarin ADR | AMRN | Nov 15, 2024 | 0.50 | -3.85 |
Amazon.com | AMZN | Nov 15, 2024 | 202.61 | -4.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.